John Friend
Amministratore Delegato presso KAZIA THERAPEUTICS LIMITED
Profilo
John E.
Friend is currently the Chief Executive Officer at Kazia Therapeutics Ltd.
Prior to his current position, he served as the Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
He then worked as the Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018, and again from 2020 to 2021.
Additionally, he held the position of Chief Medical Officer at Druggability Technologies Holdings Ltd.
(New Jersey).
Dr. Friend obtained his undergraduate degree from Southern Methodist University and his doctorate from Robert Wood Johnson Medical School.
Posizioni attive di John Friend
Società | Posizione | Inizio |
---|---|---|
KAZIA THERAPEUTICS LIMITED | Amministratore Delegato | 01/05/2023 |
Precedenti posizioni note di John Friend
Società | Posizione | Fine |
---|---|---|
CELLECTAR BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 02/11/2021 |
CELLECTAR BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 27/11/2018 |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Direttore Tecnico/Scientifico/R&S | 01/04/2017 |
Druggability Technologies Holdings Ltd. (New Jersey) | Direttore Tecnico/Scientifico/R&S | - |
Formazione di John Friend
Southern Methodist University | Undergraduate Degree |
Robert Wood Johnson Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
CELLECTAR BIOSCIENCES, INC. | Health Technology |
KAZIA THERAPEUTICS LIMITED | Health Technology |
Aziende private | 2 |
---|---|
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ. | Health Technology |
Druggability Technologies Holdings Ltd. (New Jersey) |
- Borsa valori
- Insiders
- John Friend